Anzeige
Mehr »
Mittwoch, 10.09.2025 - Börsentäglich über 12.000 News
Warum diese Aktie jetzt das perfekte Chance-Risiko-Profil für Investoren bietet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EYUN | ISIN: US14179K1016 | Ticker-Symbol: N/A
NASDAQ
18.08.25 | 21:59
4,475 US-Dollar
+0,11 % +0,005
1-Jahres-Chart  (nicht börsennotiert)
CARGO THERAPEUTICS INC Chart 1 Jahr

Aktuelle News zur CARGO THERAPEUTICS

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.08.CARGO Therapeutics, Inc. - 15-12G, Securities registration termination2
19.08.NSE - CARGO Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities1
19.08.CARGO Therapeutics, Inc. - 8-K, Current Report1
06.08.CARGO Therapeutics, Inc. - 10-Q, Quarterly Report1
CARGO THERAPEUTICS Aktie jetzt für 0€ handeln
29.07.Jefferies Raises Price Target for Cargo Therapeutics (CRGX), Keeps Hold Rating3
09.07.Concentra throws lifeline to troubled CARGO Therapeutics1
08.07.Übernahme durch Concentra: Jefferies hebt Kursziel für Cargo Therapeutics auf 5,00 Dollar an6
08.07.Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition2
08.07.CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%2
08.07.CARGO Therapeutics, Inc. - 8-K, Current Report4
08.07.Concentra to acquire CARGO Therapeutics for $4.38 per share3
08.07.Cargo Therapeutics, Inc.: CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right244SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. ("CARGO" or the "Company") (NASDAQ: CRGX), a biotechnology company that has focused on developing CAR T-cell therapies...
► Artikel lesen
20.06.CARGO Therapeutics, Inc. - 8-K, Current Report2
19.03.Pre-market Movers: Leishen Energy, Black Diamond Therapeutics, FST Corp., 5E Advanced Materials, CARGO Therapeutics1.158BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.00 A.M. ET).In the Green Leishen Energy Holding Co., Ltd. (LSE) is up over...
► Artikel lesen
18.03.After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more18
18.03.CARGO Therapeutics, Inc. - 8-K, Current Report1
18.03.Cargo Therapeutics, Inc.: CARGO Therapeutics Provides Corporate Update499- Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize shareholder value - - CARGO had cash, cash equivalents...
► Artikel lesen
30.01.Pre-market Movers: China Liberal Education, CARGO Therapeutics, Tectonic Therapeutic, Silexion Therapeutics, Banzai International1.709SANDY SPRINGS (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.35 A.M. ET).In the Green Tectonic Therapeutic, Inc. (TECX) is up over...
► Artikel lesen
29.01.Cargo Therapeutics, Inc.: CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options244CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a competitive benefit-risk profile for patients.CARGO...
► Artikel lesen
10.01.Cargo Therapeutics, Inc.: CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025479- 71 patients dosed in the potentially pivotal Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten